Chinese Pharma Recovers Most Of Contaminated Human Rabies Vaccine
This article was originally published in PharmAsia News
Executive Summary
China's Dalian Jingang-Andi Bio-products says it has recovered nearly all of the 360,200 doses of its human rabies vaccine, 20 percent of the Chinese market, found to be contaminated. The company produced the vaccine last year, but tests in January by the General Administration of Quality Supervision, Inspection and Quarantine, found an illegal nucleic acid adjuvant. The agency had announced earlier that nucleic acid materials could not be used in human vaccines until they undergo clinical trials. No deaths from the vaccine have been reported, a company spokeswoman said. (Click here for more